Product Overview

n

Redotil is a prescription medication formulated to manage acute and chronic diarrhoea. The active ingredient, racecadotril, belongs to a class of antidiarrheal agents that act locally in the intestinal tract. Each strip contains 15 capsules, and the product is marketed by Dr Reddy’s Laboratories Ltd. Available pack sizes include 30, 60, and 90 capsules, allowing patients to select the most appropriate supply for their treatment course. Delivery typically occurs within 6 to 15 days after order placement, making it a convenient option for individuals seeking reliable control of watery stools.

nn

What is Redotil?

n

Redotil is the brand name for the synthetic peptide racecadotril, which functions as a specific inhibitor of enkephalinase. By blocking enkephalinase, racecadotril increases the concentration of endogenous enkephalins in the gut, leading to a reduction in intestinal motility and fluid secretion. This mechanism distinguishes Redotil from traditional antidiarrheal drugs that primarily act on the central nervous system. The medication is indicated for the symptomatic treatment of diarrhoea of infectious or non‑infectious origin in adults and children over the age of twelve. It is not intended for use in cases of bacterial dysentery or when a specific underlying pathology has not been identified.

nn

Uses and Benefits

n

The primary benefit of Redotil is its ability to shorten the duration of diarrhoea without causing systemic sedation or constipation, which are common adverse effects of other antidiarrheal agents. Clinical studies have demonstrated that patients receiving racecadotril experience a median reduction of stool frequency by approximately 50 % within 24 hours compared with placebo. Additionally, the drug helps normalize stool consistency, decreasing the proportion of watery stools and improving patient comfort. Because it acts locally, Redotil does not significantly affect electrolyte balance, making it suitable for patients who are at risk of dehydration or electrolyte disturbances. The medication is also compatible with most standard oral rehydration solutions, allowing clinicians to combine therapy with fluid replacement without worrying about pharmacokinetic interactions.

nn

How It Works

n

Racecadotril’s pharmacological action hinges on its high affinity for the enzyme enkephalinase, which rapidly degrades enkephalin peptides that normally inhibit gastrointestinal transit. When enkephalinase is inhibited, endogenous enkephalins accumulate in the lumen, producing a potent antisecretory and antispasmodic effect. This dual action reduces the secretion of chloride and water into the intestinal lumen while simultaneously decreasing smooth‑muscle contractions. The result is a slower transit time, firmer stools, and a lower volume of diarrhoeal output. Unlike opioid‑based antidiarrheals, racecadotril’s effect is confined to the gut, minimizing the risk of central nervous system depression, respiratory depression, or dependence.

nn

Dosage Guidelines

n

Dosage of Redotil is individualized based on the severity of diarrhoea, patient age, and body weight. For adults, the recommended starting dose is 100 mg (one capsule) after each loose stool, with a maximum daily dose of 400 mg (four capsules). In pediatric patients aged 12 years and older, the same adult dosing regimen may be applied. Children between 6 and 12 years typically receive 50 mg per dose, not exceeding 200 mg per day. The capsules should be taken orally with a sufficient amount of water and can be administered with or without food. Treatment is generally limited to the acute phase of diarrhoea; if symptoms persist beyond 48 hours, a healthcare professional should be consulted for further evaluation. Patients are advised to maintain adequate hydration and to continue any prescribed oral rehydration solution throughout the course of therapy.

n

n
• Adults: 100 mg after each loose stool, up to 400 mg per day.

n

• Children 12 years and older: same adult dosing.

n

• Children 6‑12 years: 50 mg per dose, max 200 mg daily.

n

• Do not exceed the maximum daily dose.

n

• If diarrhoea resolves, discontinue medication.

n

nn

Side Effects

n

Like all pharmaceutical products, Redotil may be associated with adverse reactions, although most are mild and transient. The most frequently reported side effects include abdominal pain, headache, dizziness, and mild nausea. Rarely, patients may experience allergic skin reactions such as rash or pruritus. There have been isolated reports of elevated liver enzymes, which usually revert to normal upon discontinuation of the drug. Serious adverse events are uncommon; however, if a patient develops severe abdominal cramping, persistent vomiting, or signs of an allergic reaction (e.g., swelling of the face or throat), immediate medical attention is warranted. Healthcare providers should monitor patients with pre‑existing hepatic or renal impairment, as well as those taking concomitant medications that affect gastrointestinal motility.

nn

Warnings and Precautions

n

Redotil is contraindicated in individuals with known hypersensitivity to racecadotril or any of the excipients present in the capsule formulation. The medication should not be used in patients with acute dysentery, as it may impede the clearance of invasive pathogens. Caution is advised in patients with severe hepatic impairment, as the drug is metabolized hepatic pathways; dose adjustment may be necessary. Concomitant use of other antidiarrheal agents, especially those that act on the central nervous system, should be avoided unless directed by a physician. Pregnant and breastfeeding women should only use Redotil if the anticipated benefit justifies the potential risk, and they must discuss this with their healthcare provider. Finally, patients are reminded to store the capsules in a dry place, out of reach of children, and to discard any expired product.

nn

Frequently Asked Questions

n

n
1. Can Redotil be used for travel‑related diarrhoea? Yes, racecadotril is effective against travel‑associated watery diarrhoea when the condition is not caused by a specific bacterial pathogen that requires targeted antimicrobial therapy.

n

2. Is it safe to combine Redotil with oral rehydration salts? Absolutely. Redotil does not interfere with the electrolytes in oral rehydration solutions, and the two can be taken together to address both fluid loss and stool frequency.

n

3. How quickly does Redotil start to work? Most patients report a noticeable reduction in stool frequency within 24 hours of the first dose, with full symptomatic relief often achieved by the second or third day of treatment.

n

4. Do I need a prescription to purchase Redotil online? In most jurisdictions, Redotil is a prescription‑only medication. However, some online pharmacies may dispense it after a brief medical questionnaire reviewed by a licensed clinician.

n

5. What should I do if I miss a dose? If a scheduled dose is missed, simply resume the regular dosing schedule at the next opportunity; do not double the dose to compensate.

n

n

For more detailed prescribing information, refer to the official product monograph or consult a qualified healthcare professional.

nNational Institutes of Health (NIH) |
U.S. Food and Drug Administration (FDA) |
Drugs.com |
MedlinePlus |
Wikipedia – Racecadotriln